MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    The complex relationship between olfactory and cognitive impairment in Parkinson’s disease

    J. Djordjevic, N.S. Saadat, A. Sadikot, T. White (Montreal, QC, Canada)

    Objective: The aim of our study was to clarify the relationships between olfaction and cognition in Parkinson’s disease (PD) using a comprehensive neuropsychological battery. Background:…
  • 2017 International Congress

    Vmat2 heterozygote mice display motor dysfunction and progressive depressive-like behaviors

    K. Ma, J. Huang, L. Liu, C. Han, X. Guo, S. Guo, L. Wang, Y. Shen, Y. Xia, F. Wan, N. Xiong, T. Wang (Wuhan, China)

    Objective: To assess motor and depressive behaviors in mice that are heterozygous for VMAT2 (VMAT2 HT). Background: Dopamine (DA) is compartmentalized by the vesicular monoamine…
  • 2017 International Congress

    Lower education level is associated with greater disability from pain in Parkinson’s disease patients

    A.Q. Rana, A.R. Qureshi, Z. Sarfaraz, R. Rana (Toronto, ON, Canada)

    Objective: The objective of the current study is to explore whether a relationship between the level of educational attainment and degree of disability from pain…
  • 2017 International Congress

    Non-motor symptoms in the first neurology consultation in Cali – Colombia

    J. Valderrama-Chaparro, J. Sanchez-Morante, Y. Ariza-Araujo, A. Enriquez-Marulanda, B. Munoz, J. Orozco (cali, Colombia)

    Objective: To describe the distribution of NMS of PD in patients assisted by the Outpatient Neurology Service between 2012 and 2016 in a high level hospital…
  • 2017 International Congress

    Parkinson’s disease and progressive dysphagia – consider myasthenia gravis

    P. Urban (Hamburg, Germany)

    Objective: We report on three consecutive patients with Parkinson’s disease, in whom myasthenia gravis turned out responsible for progressive dysphagia. Background: Swallowing dysfunction is common…
  • 2017 International Congress

    Clean intermittent catheterization in Parkinson’s disease: a case report

    M. Tosin, C. Mecone, W. Macedo, A.P. Seabra, A. Barbosa, R. Sakakibara (RIO DE JANEIRO, Brazil)

    Objective: Describe the interdisciplinary actions that resulted in the therapeutic indication of a clean intermittent bladder catheterization in a patient with detrusor areflexia related to…
  • 2017 International Congress

    Phasic activity during non REM sleep

    R. Miguel, I. Arnulf (Lisboa, Portugal)

    Objective:  To describe the first reported case of behavioral and phasic neurophysiological activity during slow-wave sleep (SWS) in a patient with symtomatic REM sleep behavior…
  • 2017 International Congress

    Impact of Duopa™ on Non-Motor Symptoms of Parkinson’s Patients with Deep Brain Stimulation

    A. Wadhwa, R. Govindarajan, I. Asher (Columbia, MO, USA)

    Objective: To report the role and impact of Duopa on non-motor Parkinsonian symptoms in patients with deep brain stimulation within a month from starting therapy.…
  • 2017 International Congress

    Tongue Strength in PSP

    H. Clark, J. Whitwell, J. Ahlskog, K. Josephs (Rochester, MN, USA)

    Objective: To describe anterior and posterior tongue elevation strength in participants with PSP Background: It is widely recognized that the tongue plays a critical role…
  • 2017 International Congress

    Predictors of cognitive impairment in multiple system atrophy

    M. Hatakeyama, T. Sato, T. Takahashi, M. Kanazawa, O. Onodera, M. Nishizawa (Niigata, Japan)

    Objective: To determine predictors of cognitive impairment in patients with multiple system atrophy (MSA). Background: Although dementia is not a diagnostic criteria for MSA, an…
  • « Previous Page
  • 1
  • …
  • 1208
  • 1209
  • 1210
  • 1211
  • 1212
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • Life expectancy with and without Parkinson’s disease in the general population
    • The hardest symptoms that bother patients with Parkinson's disease
    • Patients with Essential Tremor Live Longer than their Relatives
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley